checkAd
    Startseite > Aktien > Landos Biopharma > Nachrichten
    Landos Biopharma Aktie
    0,3101
     
    USD
    0,00 %
    0,0000 USD
    Letzter Kurs 26.05.23 Nasdaq
    0,3101
     
    USD
    400 STK
    Geldkurs 25.05.23
    0,3200
     
    USD
    2.000 STK
    Briefkurs 25.05.23
    ISIN: US5150691021 · WKN: A2QNUF · SYM: LABP · USA

    Neueste Nachrichten

    LANDOS BIOPHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Landos Biopharma, Inc. - LABP
    27.03.24 · Business Wire (engl.) · Landos Biopharma
    LABP Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Landos Biopharma, Inc. Is Fair to Shareholders
    25.03.24 · Business Wire (engl.) · Landos Biopharma
    AbbVie to Acquire Landos Biopharma, Further Strengthening its Portfolio in Inflammatory and Autoimmune Diseases
    25.03.24 · globenewswire · Landos Biopharma
    Landos Biopharma Provides Business Update and Reports Fourth Quarter and Full Year 2023 Results
    21.03.24 · globenewswire · Landos Biopharma
    Landos Biopharma to Present New Data on Immunometabolism at the 19th Annual Congress of the European Crohn’s and Colitis Organisation
    08.01.24 · globenewswire · Landos Biopharma
    Landos Biopharma Publishes Results of NX-13 Phase 1b Study in Ulcerative Colitis in Journal of Crohn’s and Colitis
    21.11.23 · globenewswire · Landos Biopharma
    Landos Biopharma Provides Company Update and Reports Third Quarter 2023 Results
    09.11.23 · globenewswire · Landos Biopharma
    Landos Biopharma to Present at the American College of Gastroenterology 2023 Annual Scientific Meeting
    23.10.23 · globenewswire · Landos Biopharma
    Landos Biopharma to Present New Data on NX-13 from Phase 1b Trial in Ulcerative Colitis at United European Gastroenterology (UEG) Week 2023 Congress
    19.09.23 · globenewswire · Landos Biopharma
    Landos Biopharma Announces Strategic Research Collaboration with KU Leuven and University Hospitals Leuven to Further Characterize the Effects of NX-13 on Epithelial Cells
    14.09.23 · globenewswire · Landos Biopharma
    Landos Biopharma Provides Business Update & Reports Second Quarter 2023 Results
    09.08.23 · globenewswire · Landos Biopharma
    Landos Biopharma to Present at the 2023 Jefferies Healthcare Conference
    31.05.23 · globenewswire · Landos Biopharma